TAMPA, Fla., Jan. 04, 2022 (GLOBE NEWSWIRE) — Black Book Research received survey responses from 2,980 security and IT professionals from 877 provider…
Source: www.kulr8.com – Read more
Startup OMass Secures $310M to Advance Drug for Rare Endocrine Disorder
OMass’s molecule is vying to become an alternative to a Neurocrine Biosciences drug that is currently the only FDA-approved therapy for congenital adrenal hyperplasia. But
